A Etodolac, (S)-Isomer CEP of the European Pharmacopoeia monograph is often referred to as a Etodolac, (S)-Isomer Certificate of Suitability (COS). The purpose of a Etodolac, (S)-Isomer CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Etodolac, (S)-Isomer EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Etodolac, (S)-Isomer to their clients by showing that a Etodolac, (S)-Isomer CEP has been issued for it. The manufacturer submits a Etodolac, (S)-Isomer CEP (COS) as part of the market authorization procedure, and it takes on the role of a Etodolac, (S)-Isomer CEP holder for the record. Additionally, the data presented in the Etodolac, (S)-Isomer CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Etodolac, (S)-Isomer DMF.
A Etodolac, (S)-Isomer CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Etodolac, (S)-Isomer CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Etodolac, (S)-Isomer suppliers with CEP (COS) on PharmaCompass.